BusinessEmerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic SclerodermaBy Nasdaq OMXOct 20, 2017, 11:00 AM UTC
BusinessBioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022By Nasdaq OMXOct 19, 2017, 12:00 PM UTC
BusinessGeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine UseBy Nasdaq OMXOct 19, 2017, 11:05 AM UTC
BusinessBurner Fitness makes personalized coaching affordable for everyoneBy Nasdaq OMXOct 18, 2017, 1:00 PM UTC
BusinessGritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Novel RNA-Based Personalized Neoantigen Immunotherapies for Cancer PatientsBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessEmerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018By Nasdaq OMXOct 18, 2017, 11:01 AM UTC
BusinessMyriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza® (olaparib) in Metastatic Breast CancerBy Nasdaq OMXOct 18, 2017, 11:00 AM UTC
